• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌治疗后首次 FDG PET/CT 的最佳时机

Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.

作者信息

Leung Alan S, Rath Tanya J, Hughes Marion A, Kim Seungwon, Branstetter Barton F

机构信息

Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Department of Radiology, University of Washington School of Medicine, Seattle, Washington.

出版信息

Head Neck. 2016 Apr;38 Suppl 1:E853-8. doi: 10.1002/hed.24112. Epub 2015 Jul 18.

DOI:10.1002/hed.24112
PMID:25917499
Abstract

BACKGROUND

The optimal timing for the initial posttreatment fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT scan after definitive treatment of head and neck squamous cell carcinoma (HNSCC) is unclear.

METHODS

We conducted a retrospective review of 247 patients with definitively treated nonmetastatic HNSCC. First posttreatment PET/CT scans were grouped into: <7 weeks, 7 to 10 weeks, 11 to 14 weeks, and ≥15 weeks. Scans were categorized as positive or negative and accuracy of scans was calculated for each group using biopsy, subsequent imaging, or clinical follow-up for 1 year after treatment as a reference standard.

RESULTS

Sixty-seven of the 247 patients (27.1%) had treatment failure. Scans performed at <7 weeks were less accurate than all other time intervals (p < .05). Scans performed at all other intervals were similar in accuracy.

CONCLUSION

First posttreatment PET/CT can be obtained as early as 2 months after therapy. Scans performed earlier than 2 months have lower accuracy. © 2015 Wiley Periodicals, Inc. Head Neck 38: E853-E858, 2016.

摘要

背景

头颈部鳞状细胞癌(HNSCC)根治性治疗后首次治疗后氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)/CT检查的最佳时机尚不清楚。

方法

我们对247例接受根治性治疗的非转移性HNSCC患者进行了回顾性研究。首次治疗后PET/CT扫描分为:<7周、7至10周、11至14周和≥15周。扫描结果分为阳性或阴性,并以活检、后续影像学检查或治疗后1年的临床随访作为参考标准,计算每组扫描的准确性。

结果

247例患者中有67例(27.1%)出现治疗失败。在<7周时进行的扫描准确性低于所有其他时间间隔(p <.05)。在所有其他时间间隔进行的扫描准确性相似。

结论

首次治疗后PET/CT最早可在治疗后2个月进行。早于2个月进行的扫描准确性较低。©2015威利期刊公司。《头颈》38:E853-E858,2016。

相似文献

1
Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.头颈部鳞状细胞癌治疗后首次 FDG PET/CT 的最佳时机
Head Neck. 2016 Apr;38 Suppl 1:E853-8. doi: 10.1002/hed.24112. Epub 2015 Jul 18.
2
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.头颈部鳞状细胞癌放化疗结束3个月后,(18)氟脱氧葡萄糖正电子发射断层显像-计算机断层扫描(FDG PET-CT)用于疗效评估的准确性:至少2年的随访
Head Neck. 2016 Apr;38 Suppl 1:E1271-6. doi: 10.1002/hed.24204. Epub 2015 Aug 28.
3
Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.利用(18)F-FDG PET/CT对头颈部鳞状细胞癌根治性治疗患者亚临床复发或第二原发性癌症的检测
Head Neck. 2016 Apr;38 Suppl 1:E511-8. doi: 10.1002/hed.24032. Epub 2015 Jul 14.
4
F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.用于检测头颈癌患者复发情况的F-FDG PET/CT监测
Eur J Cancer. 2017 Feb;72:62-70. doi: 10.1016/j.ejca.2016.11.009. Epub 2016 Dec 24.
5
Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在局部晚期头颈部鳞状细胞癌同步放化疗后的应用:ECLPS 研究。
J Clin Oncol. 2017 Oct 20;35(30):3458-3464. doi: 10.1200/JCO.2017.73.5845. Epub 2017 Aug 30.
6
FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.头颈部鳞状细胞癌患者在接受或未接受放化疗的初次手术切除后进行的氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)
AJR Am J Roentgenol. 2016 May;206(5):1093-100. doi: 10.2214/AJR.15.15604. Epub 2016 Mar 21.
7
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.对头颈部癌接受根治性放射治疗的患者,使用氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(FDG-PET/CT)进行治疗后反应评估。
Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1315-22. doi: 10.1016/j.ijrobp.2006.03.015. Epub 2006 Jun 5.
8
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)在头颈部癌根治性放疗后颈部转移瘤管理中的作用。
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. doi: 10.1016/j.ijrobp.2005.03.066. Epub 2005 Aug 15.
9
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.动态三相[18F] - 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描中最大标准化摄取值斜率的变化可区分头颈部鳞状细胞癌的恶性肿瘤与放疗后炎症:一项前瞻性试验
Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):472-9. doi: 10.1016/j.ijrobp.2014.11.002. Epub 2015 Jan 30.
10
Positron-emission tomography for surveillance of head and neck cancer.用于头颈部癌症监测的正电子发射断层扫描
Laryngoscope. 2005 Apr;115(4):645-50. doi: 10.1097/01.mlg.0000161345.23128.d4.

引用本文的文献

1
Review of Outcomes after Salvage Surgery for Recurrent Squamous Cell Carcinoma of the Head and Neck.头颈部复发性鳞状细胞癌挽救性手术后的疗效综述。
Cancers (Basel). 2023 Sep 23;15(19):4692. doi: 10.3390/cancers15194692.
2
Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: Expert Panel Narrative Review.肺癌非手术治疗的影像学随访:专家小组叙述性综述。
AJR Am J Roentgenol. 2023 Oct;221(4):409-424. doi: 10.2214/AJR.23.29104. Epub 2023 Apr 5.
3
[F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging.
[F]FDG PET/CT 对头颈鳞状细胞癌的诊断:视觉评分法与多模态成像增值的头对头比较。
BMC Med Imaging. 2023 Feb 22;23(1):34. doi: 10.1186/s12880-023-00989-5.
4
Clinical Utility of Second-Look FDG PET-CT to Stratify Incomplete Metabolic Response Post (Chemo) Radiotherapy in Oropharyngeal Squamous Cell Carcinoma.二次 FDG PET-CT 在口咽鳞状细胞癌(化疗)放疗后不完全代谢反应分层中的临床应用
Cancers (Basel). 2023 Jan 11;15(2):464. doi: 10.3390/cancers15020464.
5
Utilization of PET/CT Scan in Head and Neck Carcinoma: A Tertiary Care Hospital Experience.正电子发射断层显像/X线计算机体层成像(PET/CT)扫描在头颈癌中的应用:一家三级医疗中心的经验
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2466-2471. doi: 10.1007/s12070-020-02228-7. Epub 2020 Oct 19.
6
Discordance Between Oncology Clinician-Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer.头颈部癌放疗后正电子发射断层扫描/计算机断层扫描自由格式报告中肿瘤临床医生感知和放射科医生预期含义的不一致性。
JAMA Otolaryngol Head Neck Surg. 2022 Oct 1;148(10):927-934. doi: 10.1001/jamaoto.2022.2290.
7
Performance of NI-RADS on CECT Alone to Predict Recurrent Head and Neck Squamous Cell Carcinoma after Chemoradiotherapy: Added Value of RECIST 1.1.仅使用CT增强扫描时NI-RADS对预测放化疗后复发性头颈部鳞状细胞癌的性能:RECIST 1.1的附加价值
Indian J Radiol Imaging. 2022 Jul 30;32(2):151-158. doi: 10.1055/s-0042-1754315. eCollection 2022 Jun.
8
Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌治疗后 PET/对比增强 CT 扫描上的 NI-RADS 的观察者间可靠性。
Radiol Imaging Cancer. 2021 May;3(3):e200131. doi: 10.1148/rycan.2021200131.
9
F-18 FDG PET-CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India.18F-FDG PET-CT 用于头颈部恶性肿瘤的疗效评估:来自印度南部一家三级医院的经验。
Cancer Rep (Hoboken). 2021 Jun;4(3):e1333. doi: 10.1002/cnr2.1333. Epub 2021 Mar 3.
10
Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?头颈部癌症患者治疗后无临床复发证据的影像学检查:监测影像学检查是否应延长至 6 个月以上?
AJNR Am J Neuroradiol. 2020 Jul;41(7):1238-1244. doi: 10.3174/ajnr.A6614. Epub 2020 Jun 18.